MarineMax, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-97.1% vs price
Base Case (Median)
-92.7% vs price
Bull Case (75th pct.)
-52.1% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-65.82 | -226.0% | High (40%) |
| PE Comparable | $3.19 | -93.9% | Medium (25%) |
| Growth Trajectory DCF | $3.82 | -92.7% | Medium (20%) |
| Graham Number | $12.69 | -75.7% | Medium (30%) |
| EV/EBITDA | $37.42 | -28.4% | Medium (20%) |
| EV/FCF | $159.86 | 206.0% | Medium (20%) |
| Earnings Power Value | $-0.15 | -100.3% | Medium (50%) |
Based on 7 out of 8 methods, HZO appears overvalued at the current price of $52.25. The base case fair value of $3.82 implies 92.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.